ISSN:

Journal Home

Molecular Therapy - Nucleic Acids Q1 Unclaimed

Cell Press United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Molecular Therapy - Nucleic Acids is a journal indexed in SJR in Drug Discovery and Molecular Medicine with an H index of 104. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 3285 €. The scope of the journal is focused on development of therapeutics, vector development, RNA based therapeutics, gene modifying agents, safety studies. It has an SJR impact factor of 2,046 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,046.

Molecular Therapy - Nucleic Acids focuses its scope in these topics and keywords: dna, targeting, aptamer, cells, injury, kidney, rna, activity, agents, alphabet, ...

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Drug Discovery (Q1) Molecular Medicine (Q1)

Price

3285 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

2,046

SJR Impact factor

104

H Index

274

Total Docs (Last Year)

915

Total Docs (3 years)

15042

Total Refs

5451

Total Cites (3 years)

829

Citable Docs (3 years)

5.31

Cites/Doc (2 years)

54.9

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Protein & Cell Q1
Molecular Therapy Q1
Nature Reviews Drug Discovery Q1
Medicinal Research Reviews Q1
Cell Chemical Biology Q1

Compare this journals